Browsing byAuthorWilcken, B
Showing results 1 to 8 of 8
| Issue Date | Title | Author(s) |
| 2009-02-01 | Economic evaluation of tandem mass spectrometry newborn screening in Australia | Norman, R; Haas, M; Chaplin, M; Joy, P; Wilcken, B |
| 2009-08-01 | Expanded newborn screening: Outcome in screened and unscreened patients at age 6 years | Wilcken, B; Haas, M; Joy, P; Wiley, V; Bowling, F; Carpenter, K; Christodoulou, J; Cowley, D; Ellaway, C; Fletcher, J; Kirk, EP; Lewis, B; McGill, J; Peters, H; Pitt, J; Ranieri, E; Yaplito-Lee, J; Boneh, A |
| 2007-01-01 | Healthcare Use and Costs of Medium-chain Acyl-Coa Dehydrogenase Deficiency in Australia: Screening Versus No Screening | Haas, M; Chaplin, M; Joy, P; Wiley, V; Black, C; Wilcken, B |
| 2009-03-01 | International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions | Norman, R; Haas, M; Wilcken, B |
| 2009-01-01 | Neuropsychological functioning in children with medium chain acyl coenzyme A dehydrogenase deficiency (MCADD): The impact of early diagnosis and screening on outcome | Joy, P; Black, C; Rocca, A; Haas, M; Wilcken, B |
| 2007-01-06 | Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study | Wilcken, B; Haas, M; Joy, P; Wiley, V; Chaplin, M; Black, C; Fletcher, J; McGill, J; Boneh, A |
| 2021-07-13 | Progressing our understanding of the impacts of nutrition on the brain and behaviour in anorexia nervosa: a tyrosine case study example | Hart, M; Sibbritt, D; Williams, LT; Nunn, KP; Wilcken, B |
| 2013-03-21 | Tyrosine supplementation as an adjunct treatment in anorexia nervosa - a noradrenergic repletion hypothesis | Hart, M; Wilcken, B; Williams, L; Sibbritt, D; Nunn, KP |
